These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16957809)

  • 1. Comparative efficacy and safety of deoxyarbutin, a new tyrosinase-inhibiting agent.
    Hamed SH; Sriwiriyanont P; deLong MA; Visscher MO; Wickett RR; Boissy RE
    J Cosmet Sci; 2006; 57(4):291-308. PubMed ID: 16957809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency.
    Boissy RE; Visscher M; DeLong MA
    Exp Dermatol; 2005 Aug; 14(8):601-8. PubMed ID: 16026582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DeoxyArbutin and its derivatives inhibit tyrosinase activity and melanin synthesis without inducing reactive oxygen species or apoptosis.
    Chawla S; Kvalnes K; deLong MA; Wickett R; Manga P; Boissy RE
    J Drugs Dermatol; 2012 Oct; 11(10):e28-34. PubMed ID: 23134995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives.
    Chawla S; deLong MA; Visscher MO; Wickett RR; Manga P; Boissy RE
    Br J Dermatol; 2008 Dec; 159(6):1267-74. PubMed ID: 18811684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hydroquinone and its glucoside derivatives on melanogenesis and antioxidation: Biosafety as skin whitening agents.
    Hu ZM; Zhou Q; Lei TC; Ding SF; Xu SZ
    J Dermatol Sci; 2009 Sep; 55(3):179-84. PubMed ID: 19574027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
    Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent low toxicity inhibition of human melanogenesis by novel indole-containing octapeptides.
    Ubeid AA; Do S; Nye C; Hantash BM
    Biochim Biophys Acta; 2012 Oct; 1820(10):1481-9. PubMed ID: 22609875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of arbutin on melanin biosynthesis of alpha-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues.
    Lim YJ; Lee EH; Kang TH; Ha SK; Oh MS; Kim SM; Yoon TJ; Kang C; Park JH; Kim SY
    Arch Pharm Res; 2009 Mar; 32(3):367-73. PubMed ID: 19387580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Pigmentation Effects of Eight
    Ahn HY; Choo YM; Cho YS
    J Microbiol Biotechnol; 2018 Mar; 28(3):375-380. PubMed ID: 29316744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosinase modulation by five Rwandese herbal medicines traditionally used for skin treatment.
    Kamagaju L; Morandini R; Bizuru E; Nyetera P; Nduwayezu JB; Stévigny C; Ghanem G; Duez P
    J Ethnopharmacol; 2013 Apr; 146(3):824-34. PubMed ID: 23439030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of the water-soluble polymer-wrapped derivative of fullerene on UVA-induced melanogenesis via downregulation of tyrosinase expression in human melanocytes and skin tissues.
    Xiao L; Matsubayashi K; Miwa N
    Arch Dermatol Res; 2007 Aug; 299(5-6):245-57. PubMed ID: 17333222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of melanin content by Punicalagins in the super fruit pomegranate (Punica granatum).
    Rana J; Diwakar G; Saito L; Scholten JD; Mulder T
    J Cosmet Sci; 2013; 64(6):445-53. PubMed ID: 24397882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of deoxyarbutin on melanogenesis: in vivo comparison with other melanogenesis inhibitor.
    Hamed SH; Sriwiiyanont P; Wickett RR; Boissy R
    J Cosmet Sci; 2004; 55(1):118-9. PubMed ID: 15065582
    [No Abstract]   [Full Text] [Related]  

  • 14. Arbutin: mechanism of its depigmenting action in human melanocyte culture.
    Maeda K; Fukuda M
    J Pharmacol Exp Ther; 1996 Feb; 276(2):765-9. PubMed ID: 8632348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors.
    Curto EV; Kwong C; Hermersdörfer H; Glatt H; Santis C; Virador V; Hearing VJ; Dooley TP
    Biochem Pharmacol; 1999 Mar; 57(6):663-72. PubMed ID: 10037452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrolysis of arbutin to hydroquinone by human skin bacteria and its effect on antioxidant activity.
    Bang SH; Han SJ; Kim DH
    J Cosmet Dermatol; 2008 Sep; 7(3):189-93. PubMed ID: 18789053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-sequence oligopeptides with inhibitory activity against mushroom and human tyrosinase.
    Abu Ubeid A; Zhao L; Wang Y; Hantash BM
    J Invest Dermatol; 2009 Sep; 129(9):2242-9. PubMed ID: 19440221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of Hydroquinone Mediated Cytotoxicity and Hypopigmentation Effects from UVB-Irradiated Arbutin and DeoxyArbutin.
    Chang NF; Chen YS; Lin YJ; Tai TH; Chen AN; Huang CH; Lin CC
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28467382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and safety of 4-hexyl-1,3-phenylenediol for improving skin hyperpigmentation.
    Won YK; Loy CJ; Randhawa M; Southall MD
    Arch Dermatol Res; 2014 Jul; 306(5):455-65. PubMed ID: 24402285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying melanogenesis inhibitors from Cinnamomum subavenium with in vitro and in vivo screening systems by targeting the human tyrosinase.
    Wang HM; Chen CY; Wen ZH
    Exp Dermatol; 2011 Mar; 20(3):242-8. PubMed ID: 21054558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.